Novo Nordisk Denmark A/S: Financial statements 2020
CVR: 38180045
Novo Nordisk Denmark A/S (CVR 38180045) has filed annual accounts for 2020. In 2020, the company reported revenue of DKK 330,145,351 and a net result of DKK 21,277,960 compared with DKK 5,251,810 the year before. That is a decrease of 9.3% compared with the year before. The profit margin was 6.4%. Equity amounted to DKK 36,587,365. The solvency ratio was 6.3%. The company had 152 employees in the financial year.
- Revenue
- 330,145,351 kr.
- Gross Profit
- 276,132,396 kr.
- Profit/Loss
- 21,277,960 kr.
- Equity
- 36,587,365 kr.
- Total Assets
- 584,971,435 kr.
- Employees
- 152
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | 330.1 mio. | 276.1 mio. | 21.3 mio. | 36.6 mio. | 152 |
| 2019 | 363.9 mio. | 134.9 mio. | 5.3 mio. | 15.3 mio. | 65 |
| 2018 | 341.9 mio. | 119.2 mio. | 4.2 mio. | 10.1 mio. | 69 |
How creditworthy is Novo Nordisk Denmark A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Novo Nordisk Denmark A/S has published its annual report for 2019. Revenue came to DKK 363,935,809, and the net result was DKK 5,251,810.
As of April 1, 2020, Frederik Kier has joined the board of directors of Novo Nordisk Denmark A/S.
As of April 1, 2020, Morten Berger Engelund has joined the board of directors of Novo Nordisk Denmark A/S.
As of April 1, 2020, Mads Veggerby Lausten has left the board of directors of Novo Nordisk Denmark A/S.
As of April 1, 2020, Matt Joseph Regan has left the board of directors of Novo Nordisk Denmark A/S.
About Novo Nordisk Denmark A/S
Novo Nordisk Denmark A/S is a Danish company of the type Aktieselskab based in København S, founded in 2016. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named Novo Nordisk Region Europe Pharmaceuticals A/S. The management consists of Mads Wilhelm Øckenholt Larsen. The company is owned by NOVO NORDISK REGION EUROPE A/S. The company has 81 employees. In 2025, the company reported revenue of DKK 2,504,841,000 and a net result of DKK 118,803,000 compared with DKK 86,129,000 the year before. Equity amounted to DKK 134,570,000.
